PTC
CELG

Philadelphia Trust Company’s Celgene Corp CELG Stock Holding History

Philadelphia Trust Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,990
Closed -$1.19M – 205
2019
Q3 		$1.19M Sell
11,990
-17,375
-59% -$1.65M 0.11% 103
2019
Q2 		$2.71M Sell
29,365
-3,425
-10% -$325K 0.24% 80
2019
Q1 		$3.09M Sell
32,790
-161,827
-83% -$14.2M 0.27% 76
2018
Q4 		$12.5M Sell
194,617
-447
-0.2% -$33K 1.33% 24
2018
Q3 		$17.5M Buy
195,064
+22,151
+13% +$1.96M 1.43% 21
2018
Q2 		$13.7M Sell
172,913
-12,798
-7% -$1.06M 1.23% 23
2018
Q1 		$16.6M Buy
185,711
+1,824
+1% +$175K 1.38% 23
2017
Q4 		$19.2M Buy
183,887
+34,176
+23% +$3.86M 1.51% 20
2017
Q3 		$21.8M Buy
149,711
+104,755
+233% +$14.3M 1.79% 19
2017
Q2 		$5.84M Sell
44,956
-4,410
-9% -$540K 0.5% 60
2017
Q1 		$6.14M Sell
49,366
-13,095
-21% -$1.57M 0.5% 59
2016
Q4 		$7.23M Buy
62,461
+16,135
+35% +$1.8M 0.58% 56
2016
Q3 		$4.84M Sell
46,326
-34,000
-42% -$3.68M 0.42% 60
2016
Q2 		$7.92M Sell
80,326
-10,644
-12% -$1.1M 0.69% 46
2016
Q1 		$9.11M Buy
+90,970
New +$9.37M 0.78% 43
2015
Q4 		– Sell
-5,668
Closed -$613K – 187
2015
Q3 		$613K Sell
5,668
-6,084
-52% -$755K 0.06% 115
2015
Q2 		$102K Sell
11,752
-49,601
-81% -$5.67M 0.37% 67
2015
Q1 		$7.07M Buy
61,353
+21,843
+55% +$2.61M 0.54% 54
2014
Q4 		$4.42M Buy
39,510
+28,566
+261% +$3.01M 0.36% 61
2014
Q3 		$1.04M Buy
+10,944
New +$988K 0.06% 103

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Philadelphia Trust Company's CELG Position: Q4 2019 in Review

Philadelphia Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,990 shares — an estimated $1.19M sold.

Philadelphia Trust Company first reported a position in CELG in Q3 2014 and held it in 20 quarters. The position peaked at $21.8M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Philadelphia Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Philadelphia Trust Company sold 11,990 Celgene Corp shares in Q4 2019, an estimated $1.19M.
  • Philadelphia Trust Company first reported a position in Celgene Corp in Q3 2014 and held it in 20 quarters.
  • Philadelphia Trust Company's Celgene Corp position peaked at $21.8M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Philadelphia Trust Company's 13F filing for Q4 2019, filed 10 Feb 2020.